Knowledge is power when living with alzheimers.
Get access to the web’s leading Alzheimer news & insights for as little as 16¢/day.Already a subscriber? Sign in here
Phase 1 Trial Begins Evaluating Safety of Focused Ultrasound in Alzheimer’s Patients
Insightec’s new platform, Exablate Neuro, is to be a part of the first-ever clinical trial (NCT02986932) evaluating the safety and feasibility of opening the blood-brain barrier (BBB) in Alzheimer’s disease patients at Sunnybrook Health Sciences Centre in Toronto, Canada. Exablate Neuro uses a technique called focused ultrasound, a noninvasive therapeutic technology. It applies ultrasonic energy to
I am about to become the 4th generation of women to be plagued by Alzehienmer’s disease and your study is very appealing to me.
Are any studies to be done in Arizona or close to this state.
Unfortunately, the only study evaluating the use of focused ultrasound in Alzheimer’s patients in being conducted in Canada right now. Hopefully, this trial will be a success and will move down south to the US. You can find more information at https://www.fusfoundation.org/for-patients/clinical-trials.
Thank you.
What trials we’re done to get to this point?
Will we get anything like this in the U.K.?
I will come to you in Canada to have my wife included in this possible therapy. Can you let me know the details on next steps?
hi
i am in south africa. and this looks promising. david has alzheimers 5 years now
where in south africa can we do this